Trading Signals: TGTX Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 14, 2022)(TG Therapeutics Inc)
| TGTX latest price $7.4050 (3.49%) ($7.4050 - $7.4050) on Mon. Apr. 25, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 8.07% (three month average) | RSI | 29 | Latest Price | $7.4050(3.49%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | TGTX advances 1.4% a day on average for past five trading days. | Weekly Trend | TGTX declines -14.3% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support TGTX advance at 0% a week (0% probability) XBI(75%) ARKG(70%) IBB(68%) ARKK(63%) IBUY(57%) | Factors Impacting TGTX price | TGTX will decline at least -4.035% in a week (0% probabilities). VIXM(-48%) VXX(-39%) UUP(-23%) TBT(-11%) USO(-7%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -4.035% (StdDev 8.07%) | Hourly BBV | -0.2 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-15.83(-313.77%) | Resistance Level | $8.99 | 5 Day Moving Average | $7.4(0.07%) | 10 Day Moving Average | $8.04(-7.9%) | 20 Day Moving Average | $8.99(-17.63%) | To recent high | -50.1% | To recent low | 7.4% | Market Cap | $938m | | | | TG Therapeutics, Inc. is a biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1101, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in New York, NY. |